Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active
- Resource Type
- Article
- Authors
- Garcia, Jacqueline S. ; Kim, Haesook T.; Murdock, H. Moses; Cutler, Corey S.; Brock, Jennifer; Gooptu, Mahasweta; Ho, Vincent T.; Koreth, John; Nikiforow, Sarah; Romee, Rizwan; Shapiro, Roman; Loschi, Fiona; Ryan, Jeremy; Fell, Geoffrey; Karp, Hannah Q.; Lucas, Fabienne; Kim, Annette S.; Potter, Danielle; Mashaka, Thelma; Stone, Richard M.; DeAngelo, Daniel J.; Letai, Anthony; Lindsley, R. Coleman; Soiffer, Robert J.; Antin, Joseph H.
- Source
- In Blood Advances 28 December 2021 5(24):5536-5545
- Subject
- Language
- ISSN
- 2473-9529